No Data
Collegium to Participate in Upcoming Investor Conferences
Should You Be Adding Collegium Pharmaceutical (NASDAQ:COLL) To Your Watchlist Today?
Piper Sandler Maintains Collegium Pharmaceutical(COLL.US) With Hold Rating, Maintains Target Price $36
Truist Financial Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating
Needham Maintains Collegium Pharmaceutical(COLL.US) With Buy Rating, Maintains Target Price $46
Positive Outlook for Collegium Pharmaceutical: Strong Performance and Strategic Growth Initiatives Support Buy Rating
Can Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Improve Its Returns?